Radium-223 In The Treatment Of Metastatic Castration-Resistant Prostate Cancer

被引：0
|
作者：
Vazzana, C. [1 ]
Morano, S. [2 ]
Di Lascio, A. [3 ]
Grana, C. [4 ]
Chinol, M. [4 ]
机构：
[1] Veneto Oncol Inst IOV IRCCS, Padua, Italy
[2] Hosp Bianchi Melacrino Morelli, Reggio Di Calabria, Italy
[3] Hosp A Cardarelli, Naples, Italy
[4] European Inst Oncol, Milan, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2017年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
E-TPW39
引用
收藏
页码：S880 / S880
页数：1
相关论文
共 50 条
  • [41] Radium-223 in metastatic castration-resistant prostate cancer: current status and future perspectives
    Wyndaele D.N.J.
    Tijdschrift voor Urologie, 2020, 10 (6-7) : 131 - 140
  • [42] Radium-223 plus abiraterone in metastatic castration-resistant prostate cancer: a cautionary tale
    Sedhom, Ramy
    Antonarakis, Emmanuel S.
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2019, 8 : S341 - S345
  • [43] Radium-223: Insight and Perspectives in Bone-metastatic Castration-resistant Prostate Cancer
    Buroni, Federica Eleonora
    Persico, Marco Giovanni
    Pasi, Francesca
    Lodola, Lorenzo
    Nano, Rosanna
    Aprile, Carlo
    ANTICANCER RESEARCH, 2016, 36 (11) : 5719 - 5730
  • [44] Correction to: Dutch Economic Value of Radium-223 in Metastatic Castration-Resistant Prostate Cancer
    Michel L. Peters
    Claudine de Meijer
    Dirk Wyndaele
    Walter Noordzij
    Annemarie M. Leliveld-Kors
    Joan van den Bosch
    Pieter H. van den Berg
    Agni Baka
    Jennifer G. Gaultney
    Applied Health Economics and Health Policy, 2018, 16 : 145 - 145
  • [45] The role of radium-223 in the evolving treatment landscape of metastatic castration-resistant prostate cancer: A narrative review
    Pinto, Alvaro
    Dominguez, Mario
    Gomez-Iturriaga, Alfonso
    Rodriguez-Vida, Alejo
    Vallejo-Casas, Juan Antonio
    Castro, Elena
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2025, 210
  • [46] Radium-223 dichloride for the treatment of bone metastatic castration-resistant prostate cancer: an evaluation of its safety
    Nilsson, Sten
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (07) : 1127 - 1136
  • [47] Impact of treatment delay in Radium-223 Dichloride therapy of metastatic castration-resistant prostate cancer patients
    Fosbol, M. O.
    Holm, S.
    Petersen, P. M.
    Daugaard, G.
    Mortensen, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S214 - S214
  • [48] Predictors for survival after radium-223 (R223) treatment for castration-resistant metastatic prostate cancer.
    Anderson, Eric
    Wong, William
    Mohammadi, Homan
    Daniels, Thomas Backus
    Tzou, Katherine S.
    Schild, Steven E.
    Keole, Sameer R.
    Choo, Richard
    Bryce, Alan H.
    Thai Huu Ho
    Quevedo, Fernando
    Vora, Sujay A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [49] Combination Therapy With Radium-223 and Enzalutamide in Castration-Resistant Prostate Cancer
    Maughan, Benjamin L.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (12) : 764 - 766
  • [50] Radium-223 for the treatment of bone metastases in castration-resistant prostate cancer: when and why
    Gallicchio, Rosj
    Mastrangelo, Pietro A.
    Nardelli, Anna
    Mainenti, Pier Paolo
    Colasurdo, Antonio P.
    Landriscina, Matteo
    Guglielmi, Giuseppe
    Storto, Giovanni
    TUMORI JOURNAL, 2019, 105 (05): : 367 - 377
12345